📊 AHR Key Takeaways
Is American Healthcare REIT, Inc. (AHR) a Good Investment?
American Healthcare REIT demonstrates solid operational performance with 7.9% revenue growth and strong free cash flow generation of $294.4M, supported by a healthy 4.8x interest coverage ratio and conservative 0.30x debt-to-equity leverage. However, the 1.3% ROA and 2.1% ROE indicate weak capital efficiency, while declining net income (-1.4% YoY) despite revenue growth raises concerns about operational expense management and profitability sustainability.
American Healthcare REIT shows solid top-line growth, positive operating leverage, and healthy cash generation, supported by a relatively conservative balance sheet for a REIT. However, weak net margin, low ROE/ROA, and slightly declining net income suggest that growth quality is only moderate and that profitability remains thin despite improved EPS.
Why Buy American Healthcare REIT, Inc. Stock? AHR Key Strengths
- Strong free cash flow of $294.4M with 13.0% FCF margin provides reliable distribution capacity
- Conservative leverage at 0.30x debt-to-equity with comfortable 4.8x interest coverage ratio indicates financial stability
- Solid revenue growth of 7.9% YoY demonstrates market demand in healthcare real estate segment
- Revenue growth of 7.9% with positive operating income and an 18.4% operating margin
- Conservative leverage profile with 0.30x debt-to-equity and manageable 4.8x interest coverage
- Positive operating cash flow of $294.44M and a 13.0% free cash flow margin
AHR Stock Risks: American Healthcare REIT, Inc. Investment Risks
- Declining net income (-1.4% YoY) despite revenue growth suggests deteriorating operational profitability or rising expenses
- Very low return metrics (1.3% ROA, 2.1% ROE) indicate inefficient capital deployment and weak capital utilization
- Minimal net margin at 3.1% leaves limited buffer for operational challenges or interest rate shocks
- Net income declined 1.4% year over year despite revenue growth, indicating margin pressure or higher below-the-line costs
- Net margin of 3.1% and low ROE of 2.1% point to limited profitability and weak capital efficiency
- Cash balance of $114.84M is modest relative to asset size and debt obligations, reducing flexibility if operating conditions weaken
Key Metrics to Watch
- Net income trend and margin expansion to confirm operational performance stabilization
- Return on assets and equity improvement through enhanced capital efficiency
- Debt-to-equity ratio and interest coverage maintenance as rates potentially remain elevated
- Net income and net margin trend relative to revenue growth
- Operating cash flow coverage of interest expense and debt obligations
American Healthcare REIT, Inc. (AHR) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
AHR Profit Margin, ROE & Profitability Analysis
AHR vs Real Estate Sector: How American Healthcare REIT, Inc. Compares
How American Healthcare REIT, Inc. compares to Real Estate sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is American Healthcare REIT, Inc. Stock Overvalued? AHR Valuation Analysis 2026
Based on fundamental analysis, American Healthcare REIT, Inc. has mixed fundamental signals relative to the Real Estate sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
American Healthcare REIT, Inc. Balance Sheet: AHR Debt, Cash & Liquidity
AHR Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: American Healthcare REIT, Inc.'s revenue has grown significantly by 86% over the 5-year period, indicating strong business expansion. The most recent EPS of $-1.08 indicates the company is currently unprofitable.
AHR Revenue Growth, EPS Growth & YoY Performance
AHR Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $476.8M | -$4.1M | $-0.03 |
| Q2 2025 | $458.0M | -$1.9M | $0.01 |
| Q1 2025 | $452.1M | -$3.9M | $-0.04 |
| Q3 2024 | $416.2M | -$4.1M | $-0.03 |
| Q2 2024 | $410.6M | -$1.9M | $0.01 |
| Q1 2024 | $408.6M | -$3.9M | $-0.04 |
| Q3 2023 | $368.3M | -$6.0M | $-0.09 |
| Q2 2023 | $326.2M | -$12.2M | $-0.19 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
American Healthcare REIT, Inc. Dividends, Buybacks & Capital Allocation
AHR SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for American Healthcare REIT, Inc. (CIK: 0001632970)
📋 Recent SEC Filings
❓ Frequently Asked Questions about AHR
What is the AI rating for AHR?
American Healthcare REIT, Inc. (AHR) has a Combined AI Rating of HOLD from Claude (HOLD) and ChatGPT (HOLD) with 70% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are AHR's key strengths?
Claude: Strong free cash flow of $294.4M with 13.0% FCF margin provides reliable distribution capacity. Conservative leverage at 0.30x debt-to-equity with comfortable 4.8x interest coverage ratio indicates financial stability. ChatGPT: Revenue growth of 7.9% with positive operating income and an 18.4% operating margin. Conservative leverage profile with 0.30x debt-to-equity and manageable 4.8x interest coverage.
What are the risks of investing in AHR?
Claude: Declining net income (-1.4% YoY) despite revenue growth suggests deteriorating operational profitability or rising expenses. Very low return metrics (1.3% ROA, 2.1% ROE) indicate inefficient capital deployment and weak capital utilization. ChatGPT: Net income declined 1.4% year over year despite revenue growth, indicating margin pressure or higher below-the-line costs. Net margin of 3.1% and low ROE of 2.1% point to limited profitability and weak capital efficiency.
What is AHR's revenue and growth?
American Healthcare REIT, Inc. reported revenue of $2.3B.
Does AHR pay dividends?
American Healthcare REIT, Inc. pays dividends, with $163.5M distributed to shareholders in the trailing twelve months.
Where can I find AHR SEC filings?
Official SEC filings for American Healthcare REIT, Inc. (CIK: 0001632970) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is AHR's EPS?
American Healthcare REIT, Inc. has a diluted EPS of $0.42.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is AHR a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, American Healthcare REIT, Inc. has a HOLD rating with 70% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is AHR stock overvalued or undervalued?
Valuation metrics for AHR: ROE of 2.1% (sector avg: 8%), net margin of 3.1% (sector avg: 20%). Compare these metrics with sector averages to assess valuation.
Should I buy AHR stock in 2026?
Our dual AI analysis gives American Healthcare REIT, Inc. a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is AHR's free cash flow?
American Healthcare REIT, Inc.'s operating cash flow is $294.4M, with capital expenditures of $0.0. FCF margin is 13.0%.
How does AHR compare to other Real Estate stocks?
Vs Real Estate sector averages: Net margin 3.1% (avg: 20%), ROE 2.1% (avg: 8%), current ratio N/A (avg: 1.5).